The role of chemokines in melanoma tumor growth and metastasis

Journal of Investigative Dermatology

Volumn 118, Issue 6, 2002, Pages 915-922

  Payne, Aimee S ^a   Cornelius, Lynn A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokine; Chemokine receptor; G protein coupled receptor; Melanocyte; Melanoma

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 8; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN SUBUNIT; PROTEINASE; RANTES; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANGIOGENESIS; CARCINOGENESIS; CELL INFILTRATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; ENZYME INDUCTION; HUMAN; LEUKOCYTE; MELANOMA; MELANOMA CELL; METASTASIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; TUMOR GROWTH;

EID: 0036270898     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2002.01725.x     Document Type: Review

References (121)

1. Induction of natural killer cell migration by monocyte chemoattractant protein-1, -2 and -3
2. Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells
3. RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation
4. RANTES, a versatile and controversial chemokine
5. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils
6. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines
7. Effects of MGSA/GRO alpha on melanocyte transformation
8. Inflammation and cancer: Back to Virchow?
9. CXC chemokines in angiogenesis
10. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism and disease
11. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells
12. Characterization of the role of melanoma growth stimulating activity MGSA in the growth of normal melanocytes, nevocytes and malignant melanocytes
13. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2
14. -1- mice reveals a role for chemokines in the initiation of atherosclerosis
15. Melanoma vaccines
16. Inflammatory cell infiltrates in human melanoma at different stages of tumor progression
17. Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation
18. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant
19. Genomic analysis of metastasis reveals an essential role for Rho C
20. Expression of cytokine genes, including IL- 6, in human malignant melanoma cell lines
21. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells
22. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites
23. The role of MHC class I glycoproteins in the regulation of induction of cell death in immunocytes by malignant melanoma cells
24. Human melanoma cells produce interleukin-8 which functions as an autocrine growth factor
25. CCR7 coordinates the primary immature response by establishing functional microenvironments in secondary lymphoid organs
26. A synthetic peptide inhibitor for α-chemokines inhibits the tumor growth and pulmonary metastasis of human melanoma cells in nude mice
27. The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes
28. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils
29. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice
30. CC chemokine receptor 7 (CCR-7) - Transduced B16 melanoma cells show enhanced early metastasis to regional lymph nodes
31. Expression of monocyte chemotactic protein-1 in human melanoma in vivo
32. The familial occurrence of cutaneous melanoma, intraocular melanoma, and the dysplastic nevus syndrome
33. Linkage analysis in Dutch familial atypical multiple mole-melanoma syndrome families. Effect of naevus count
34. Regulation of interleukin-8 expression in human melanoma cells by the organ environment
35. HIV-specific T cell cytotoxicity mediated by RANTES via the chemokine receptor CCR3
36. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma
37. Receptor recognition and specificity of interleukin-8 is determined by residues that cluster near a surface-accessible hydrophobic pocket
38. Identiffication of three related human GRO genes encoding cytokine functions
39. Immunohistochemical localization of CD1a-positive putative tumor infiltrating dendritic cells in human breast tumors
40. Coexpression of integrin avb3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: Correlation with melanoma progression
41. Novel CXCR2-dependent liver regenerative qualities of ELR-containing CXC chemokines
42. Structure and functional expression of a human interleukin- 8 receptor
43. Cutting edge: The orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTAK/ALP/ILC)
44. Germline p 16 mutations in familial melanoma
45. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine
46. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684
47. The CXC receptor 2 is overexpressed in psoriatic epidermis
48. Defects in macrophage recruitment and host defense in mice lacking the CCR 2 chemokine receptor
49. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2
50. Preparation of a monoclonal antibody to a melanoma growth-stimulatory activity released into serum-free culture medium by Hs0294 malignant melanoma cells
51. Characterization of two high affinity human interleukin-8 receptors
52. Chemokine binding and activities mediated by the mouse IL-8 receptor
53. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis
54. Chemokines as regulators of T cell differentiation
55. "Proteolytic switching" opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression
56. The origin and function of tumor-associated macrophages
57. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor
58. Regulation of interleukin-8 mRNA expression and protein secretion in a melanoma cell line by tumor necrosis factor-alpha and interferon-gamma
59. HIV type 1 coreceptors, neutralization serotypes, and vaccine development
60. CTAK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells
61. The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice
62. Melanoma growth stimulatory activity enhances the phosphorylation of the class II interleukin-8 receptor in non-hematopoietic cells
63. Activation of protein kinase C enhances the phosphorylation of the type B interleukin-8 receptor and stimulates its degradation in non-hematopoietic cells
64. Ligand-induced desensitization of the human CXC chemokine receptor-2 is modulated by multiple serine residues in the carboxyl-terminal domain of the receptor
65. Interleukin 8. An expanding universe beyond neutrophil chemotaxis and activation
66. Involvement of chemokine receptors in breast cancer metastasis
67. Chemokine receptors: Structure, function and role in microbial pathogenesis
68. Cloning of complementary DNA encoding a functional human interleukin-8 receptor
69. Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells
70. Family studies in melanoma: Identification of atypical mole syndrome
71. Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations
72. Polarization of chemokine receptors to the leading edge during lymphocyte chemotaxis
73. Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells
74. T-cell subsets: Chemokine receptors guide the way
75. Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine β and γ proteins
76. Neutrophil-activating peptides NAP-2 and IL-8 bind to the same sites on neutrophils but interact in different ways: Discrepancies in binding affinities, receptor densities, and biologic effects
77. Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: A clinic-based population study
78. Hereditary cutaneous melanoma
79. Characterization of autostimulatory and transforming growth factors from human melanoma cells
80. Purification of melanoma growth stimulatory activity
81. Molecular characterization of melanoma growth stimulatory activity, a growth factor structurally related to β-thromboglobulin
82. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial mediates angiostatic activity
83. Potential role of the chemokine receptors CXCR3, CCR4 and integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris
84. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein cells
85. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells
86. Flexible programs of chemokine receptor expression in human polarized T helper 1 and 2 lymphocytes
87. The role of chemokine receptors in primary effector and memory immune responses
88. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor
89. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
90. Biology of the RANTES/SIS cytokine family
91. Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells
92. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity
93. IL-1α or tumor necrosis factor-α stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts
94. Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity
95. Enhanced degradation of IkB contributes to endogenous activaiton of NFkB
96. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes
97. Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associates with human ovarian carcinoma
98. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice
99. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8
100. Regulation of interleukin 8 expression in human malignant melanoma cells
101. Cutting edge: Differential regulation of chemokine receptors during dendritic maturation: A model for their trafficking properties
102. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis
103. Macrophage infiltration correlates with tumor stage and angiogenesis in human melanoma Possible involvement of TNF-α and IL-1α
104. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis and survival in human breast cancer
105. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture
106. Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity
107. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes
108. IL-8 induces haptotaxis and chemotaxis of melanoma cells
109. Chemokines: Understanding their role in T-lymphocyte biology
110. Oct-1 and CCAAT/enhancer-binding protein (C/EBP) bind to overlapping elements within the interleukin-8 promoter: The role of Oct-1 as a transcriptional repressor
111. Constitutive Ikb kinase activity correlates with nuclear factor-kB activation in human melanoma cells
112. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma
113. Role of clathrin-mediated endocytosis in CXCR2 sequestration, resensitization and signal transduction
114. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions
115. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines
116. Human monocyte chemoattractant protein-1. Full length DNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE
117. Interferon-gamma increases expression of chemokine receptors CCR1, CCR3 and CCR5, but no CXCR4 in monocytoid U937 cells
118. Retinoblastoma protein expression leads to reduced Oct-1 DNA binding activity and enhances interleukin-8 expression
119. The chemokine receptor CCR8 is preferentially expressed in Th2 but not in Th1 cells
120. Chemokines: A new classification system and their role in immunity